Please login to the form below
tuberculosis
This page shows the latest tuberculosis news and features for those working in and with pharma, biotech and healthcare.
Pharma must do more on antibiotic resistance, Davos meeting hears
for AMR and bring them to market responsibly, ”citing the case of J&J’s new tuberculosis drug bedaquiline which is available in 100 countries with tight control of access.
Latest news
-
J&J expands its TB research programme
Johnson and Johnson (J&J) has partnered with the Institute of Microbial Technology (IMTECH), part of the Council of Scientific and Industrial Research (CSIR), to develop new treatments for tuberculosis (TB).
-
Just 20% of people living with hep C are aware of their status
The number of deaths attributed to viral hepatitis is comparable to those caused by tuberculosis and higher than those caused by HIV, but deaths from hepatitis are increasing while tuberculosis and
-
Dosing of GSK's malaria vaccine due to start in 2018
The Global Fund to Fight AIDS, Tuberculosis and Malaria has just approved $15m in funding for the malaria vaccine pilots, that according to the WHO assures full funding for the first
-
The global scourge of counterfeit medicines
Tuberculosis treatments. 19, 403, 468. Erectile dysfunction. 5, 830, 570. Antibiotics.
-
AZ, BMS and Boehringer among UK Prix Galien finalists
Janssen's Sirturo, the first tuberculosis medication to be approved in four decades.
More from news
Approximately 16 fully matching, plus 125 partially matching documents found.
Latest Intelligence
-
The cultural construction of illness
and ‘consumptive’appearance, driven by the perception of a link between tuberculosis and creativity.
-
Reactivating drug research programmes
One research-led breakthrough to hit the headlines involves the use of genome sequencing to isolate different strains of tuberculosis (TB), allowing the disease to be diagnosed more quickly.
-
Deal Watch February 2016
acquisition - company. 7, 200. Alere/Abbott Laboratories. portfolio of point of care diagnostics for infections such as HIV, tuberculosis, malaria, dengue.
-
Searching for health
We bring products to the market regularly.”. Success in HIV and multi-drug resistant tuberculosis are the highlights but Quiles is conscious of the need to translate innovation into market penetration.
-
The AMR threat
country. The misuse and overuse of antibiotics in humans and animals is causing resistance to accelerate and leading to a growing number of infections - among them pneumonia, tuberculosis and gonorrhoea - becoming
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Former Merck & Co exec to lead Seres
In total Dr Pomerantz has been involved with the development of eight approved drugs for infectious diseases, covering HIV, hepatitis C and tuberculosis.
-
GlycoVaxyn appoints Gerd Zettlmeissl as chairman
He currently serves on the boards of several biotechnology companies including Aeras, an organisation dedicated to the development of tuberculosis vaccines.
-
Former PEPFAR head Mark Dybul to lead the Global Fund
Former PEPFAR head Mark Dybul to lead the Global Fund. Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation. ... The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark
More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Could ketamine be the next big thing in depression?
Doctors noticed that tuberculosis patients treated with isoniazid showed signs of improved mood.
-
Exploring MINT: Part 4 - Turkey
In Eastern Turkey, outbreaks of communicable diseases such as tuberculosis are still occurring.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Medical Writer, e-learning/ training, London
-
Excellent Salary
-
Senior Medical Writer
-
Great salary and benefits
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Group Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior Account Manager / Account Director
-
Great salary and bebefits
-
Scientific Director
-
Great salary and bebefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Account Manager – Med Comms – London
-
Salary TBC
Subscribe to our email news alerts
- Artificial intelligence in healthcare ‘set for 40% growth to 2024’
- Moving annual total (MAT)
- GSK hands rare disease assets over to Orchard
- Novo Nordisk appoints new general manager
- Beyond caring: learning from the unsung advocates in cancer care
- AZ makes case for first-line Tagrisso therapy in lung cancer
- The threat of antimicrobial resistance
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Wordbird strikes CPD gold in their first year of IPA membership – the only agency to achieve this accolade this year
- Unique forum will unite NHS and industry to drive innovation
- Good Relations win Nuffield Health account
- Amgen and Novartis migraine drug hits the mark again
PMHub
WCG
WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...
Latest intelligence
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
- Unique forum will unite NHS and industry to drive innovation
- HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...
Quick links
Infographics
